| Stage | SHLS | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $195M | 100.00% | $96.2B | 100.00% | NVDA ×492.66 |
| Gross profit | $62M | 31.95% | $72.1B | 74.98% | NVDA +43.0pp |
| Operating income | $29M | 14.83% | $63.7B | 66.24% | NVDA +51.4pp |
| Pre-tax income | $24M | 12.33% | $71.5B | 74.32% | NVDA +62.0pp |
| Net income | $18M | 9.15% | $59.7B | 62.03% | NVDA +52.9pp |
| Stage | SHLS | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $195M100.00% | $96.2B100.00% | NVDA ×492.66 |
| Gross profit | 31.95%$62M | 74.98%$72.1B | NVDA +43.0pp |
| Operating income | 14.83%$29M | 66.24%$63.7B | NVDA +51.4pp |
| Pre-tax income | 12.33%$24M | 74.32%$71.5B | NVDA +62.0pp |
| Net income |
| 9.15%$18M |
| 62.03%$59.7B |
| NVDA +52.9pp |